Clinical trial
T-cell Response-Flu Risk in Older Adults
NCT00138398 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00138398 |
|---|---|
| Title | T-cell Response-Flu Risk in Older Adults |
| Official title | T-cell Responses Predict Influenza Risk in Older Adults |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Commercial TriValent Split Influenza Virus |
| Enrollment | 850 |
| Start date | Oct 25, 2005 |
| First posted | Aug 30, 2005 |
| Last update posted | Feb 15, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: